factual
FDA approves faster than Europe via accelerated approval
The FDA is more liberal than European authorities in approving drugs, willing to grant accelerated approval based on smaller single-arm studies for life-threatening diseases—approving a drug that helped 30 of 200 patients with no good alternative while the company promises a controlled trial later—so myeloma drugs reached the U.S. years before the rest of the world, which is good for patients.
factualpending
Speaker
Vincent RajkumarEvidence Quote
“All of the myeloma drugs were available in the United States years before what they were in the rest of the world. So, the FDA is really good about that”
Created: 6/13/2026, 12:13:30 AM
Your notes
Loading notes...